You are here: Industry Insights > license

News List

Celltrion signs agreement for atherosclerosis drugs development biospectrumasia
October 15, 2018
Celltrion will have a preferential right to license-in the new drug candidates
Novartis Enters into License Agreement with Galapagos, MorphoSys americanpharmaceuticalreview
July 24, 2018
Novartis has entered into an exclusive license agreement with biotech companies Galapagos NV, Mechelen and MorphoSys regarding their compound MOR106.
Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe b3cnewswire
July 04, 2018
Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar (HD201; Hervelous™) in Central an
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and worldpharmanews
April 17, 2017
Bristol-Myers Squibb Company (NYSE:BMY) announced that it has entered into two separate agreements to license BMS-986168 to Biogen and BMS-986089 to Roche.
Ligand Expands Sermonix License to Oral Lasofoxifene contractpharma
March 02, 2017
Gains global development and commercialization rights
Mayne Pharma Enters License/Supply Pact contractpharma
March 01, 2017
Mayne Pharma Inc. has entered into a long-term, exclusive license and supply agreement with Mithra Pharmaceuticals SA for Myring, an intravaginal hormonal contraceptive delivery device.

Previous page 1 2 Next page